Sertraline is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class, sold under brand names including Zoloft and Lustral. Developed by Pfizer and approved for medical use in 1991, it is prescribed for major depressive disorder, anxiety disorders, obsessive-compulsive disorder, panic disorder, and other psychiatric conditions. Sertraline became one of the most commonly prescribed psychotropic medications worldwide and is included on the World Health Organization's List of Essential Medicines.
Sertralín molecular structure diagram from the DrugsPRO substance library.
Also known as: Zoloft, Lustral
Classification
Chemical: Medicine
Tag: Antidepressant
Tag: Naphthalene derivative
Tag: Pharmaceutical
Tag: Ssri
Effects
Anxiolysis
Excessive Yawning
Pupil Dilation
Temperature Regulation Suppression
Increased Heart Rate
Tremor
Mood Lift
Anxiety
Irritability
Emotionality Suppression
Confusion
Cognitive Fatigue
Dehydration
Sexual Dysfunction
Auditory Hallucination
Visual Acuity Suppression
External Hallucination
Light Sensitivity
Routes of Administration
Oral
Dosage
Heavy: 400 mg
Light: 25 – 50 mg/day
Common: 50 – 200 mg
Strong: 200 – 400 mg
Threshold: 25 mg/day
Duration
No data available for this section yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
This static page is intended as a readable non-JS and prerender-friendly library export.
Get the full DrugsPRO experience
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
Sertraline - DrugsPRO sprievodca látky
Sertraline: Sertraline is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class, sold under brand names including Zoloft and Lustral. Developed by Pfizer and approved for medical use in 1991, it is prescribed for major depressive disorder, anxiety disorders, obsessive-compulsi